Shi‐Shan Mao

1.0k citations
18 papers · 617 indexed · h-index 12
Topics
Blood Coagulation and Thrombosis Mechanisms (7 papers)Peptidase Inhibition and Analysis (6 papers)Protease and Inhibitor Mechanisms (3 papers)
Partner nations
United StatesTaiwan

In The Last Decade

Shi‐Shan Mao

18 papers receiving 581 citations

Peers

Shi‐Shan Mao
Comparison fields: 5 of 86
  • Molecular Biology 211
  • Hematology 192
  • Organic Chemistry 104
  • Infectious Diseases 99
  • Oncology 76
Replace Amit Shah with:
Amit Shah United States
Federico Falchi Italy
Gaëlle Noé France
Jerry W. Skiles United States
Hans Weber Germany
Stanley L. Gaul United States
Mariangela Agamennone Italy
Wei Jia China
Roopa Rai United States
Cynthia Parker United States
Shi‐Shan Mao relative to Amit Shah United States Amit Shah's profile →
Citations per field
00.5×9.5×
Amit Shah · 1×
Citations per year

Countries citing papers authored by Shi‐Shan Mao

Since Specialization
Citations

This map shows the geographic impact of Shi‐Shan Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi‐Shan Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi‐Shan Mao more than expected).

Fields of papers citing papers by Shi‐Shan Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi‐Shan Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi‐Shan Mao. The network helps show where Shi‐Shan Mao may publish in the future.

Co-authorship network of co-authors of Shi‐Shan Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Shi‐Shan Mao. A scholar is included among the top collaborators of Shi‐Shan Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi‐Shan Mao. Shi‐Shan Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 130
2 77
3 23
4 30
5 48
6 27
7 36
8 13
9 105
10 7
11 2
12 9
13 53
14 16
15 23
16 8
17 7
18 3

About Shi‐Shan Mao

Shi‐Shan Mao is a scholar working on Hematology, Oncology and Hepatology, having authored 18 papers that have together received 617 indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (7 papers), Peptidase Inhibition and Analysis (6 papers) and Protease and Inhibitor Mechanisms (3 papers). The work is most often cited by research in Hematology (192 citations), Hepatology (67 citations) and Internal Medicine (25 citations). Shi‐Shan Mao has collaborated with scholars based in United States and Taiwan. Frequent co-authors include Stephen J. Gardell, Jules A. Shafer, Steven S. Carroll, Carolyn M. Cooper, Theresa Wood, Dennis Colussi, Joseph P. Vacca, Christine Burlein, Ying‐Ta Wu and Wei-Chieh Cheng. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026